Link Between Actos and Bladder Cancer
A recent study has detected an unusually high number of reports of bladder cancer that appear to be linked to the diabetes drug Actos. The lawyers at Saiontz & Kirk, P.A. are reviewing potential Actos lawsuits for individuals diagnosed with bladder cancer to determine whether financial compensation may be available as a result of the manufacturer’s failure to adequately warn about the risk of problems.
>>MORE INFORMATION: Actos Side Effects
According to a new study published in April in the medical journal Diabetes Care, more than a fifth of all bladder cancer reports submitted to the FDA’s Adverse Event Reporting System between 2004 and 2009 that were linked to a diabetes drug were from Actos users. This provides further support for a potential link between Actos and bladder cancer.
Last September, the FDA launched an safety review of Actos based on suspicions that it could be linked to bladder cancer. That review was initiated after 5-year data from an on-going 10-year study of Actos by its manufacturer, Takeda Pharmaceuticals, suggested that there may be a risk of bladder cancer for Actos users the longer the medication is taken.
After evaluating interim data from the on-going study involving 193,099 diabetes patients, it was discovered that after two years of using Actos, the risk of bladder cancer became statistically significant.
ACTOS LAWSUITS FOR BLADDER CANCER
The product liability lawyers at Saiontz & Kirk, P.A. are evaluating potential lawsuits for bladder cancer from Actos on behalf of individuals throughout the United States. As a result of the manufacturer’s failure to adequately research their medication or warn about the potential link between bladder cancer and Actos, compensation may be available.
To review a potential case for yourself, a friend or family member with one of our Actos attorneys, request a free consultation and claim evaluation.